Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,210 | -3,067 | -1,077 | -3,193 | -2,729 |
| Depreciation Amortization | N/A | N/A | N/A | 0 | 2 |
| Accounts receivable | N/A | N/A | N/A | N/A | 118 |
| Accounts payable and accrued liabilities | -1,051 | -1,390 | -1,752 | N/A | 1,821 |
| Other Working Capital | -4,175 | -1,412 | -1,736 | 2,627 | 2,033 |
| Other Operating Activity | 1,822 | 2,415 | 1,888 | 67 | -1,939 |
| Operating Cash Flow | $-9,614 | $-3,454 | $-2,677 | $-499 | $-694 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | -14 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-14 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,112 | 21,614 | N/A | N/A | N/A |
| Other Financing Activity | 1,291 | 1,291 | 3,295 | 734 | 532 |
| Financing Cash Flow | $23,403 | $22,905 | $3,295 | $734 | $532 |
| Exchange Rate Effect | 45 | N/A | -51 | 8 | -19 |
| Beginning Cash Position | 427 | 427 | 427 | 198 | 198 |
| End Cash Position | 14,262 | 19,878 | 994 | 427 | 18 |
| Net Cash Flow | $13,834 | $19,451 | $567 | $229 | $-180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,614 | -3,454 | -2,677 | -499 | -694 |
| Free Cash Flow | -9,614 | -3,454 | -2,677 | -499 | -694 |